Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: India's Jubilant Pharmova Posts Dec-Quarter Consol Loss Vs Profit

Feb 3 (Reuters) - Jubilant Pharmova Ltd  JUBA.NS :
    * DEC-QUARTER CONSOL NET LOSS 156.7 MILLION RUPEES VERSUS
PROFIT
509.9 MILLION RUPEES
    * DEC-QUARTER CONSOL SALES 1.53 BILLION RUPEES VERSUS 1.30
BILLION
RUPEES
    * IN FY24, PROFITABILITY EXPECTED TO IMPROVE DRIVEN BY
RADIOPHARMACEUTICALS, ALLERGY IMMUNOTHERAPY, CDMO STERILE
INJECTABLES
    * CAPEX PLAN UNDERWAY FOR ADDITIONAL BUILDING BLOCK IN
GREATER
NOIDA FACILITY

Source text for Eikon:  ID:nNSE5djR5R 
Further company coverage:  JUBA.NS 
 ((reuters.briefs@thomsonreuters.com;))

Recent news on Jubilant Pharmova

See all news